Emgality (galcanezumab-gnlm) is Eli Lilly's subcutaneous CGRP monoclonal antibody indicated for the preventive treatment of migraine in adults.
Competing Products
Eli Lilly and Company
Global pharmaceutical innovator for humans and animals. Pioneering neuroscience, endocrine, oncology, and animal health solutions.
Founded
1876Founded in 1876 by Colonel Eli Lilly in Indianapolis, Indiana, Eli Lilly and Company is a global pharmaceutical innovator dedicated to discovering, developing, and marketing human and animal health solutions. The company's core mission is to make life better for people around the world through innovative medicines. Eli Lilly offers a wide range of products, including treatments for diabetes such as Humalog and Trulicity, oncology medications like Alimta, and various other pharmaceuticals targeting neuroscience and endocrine disorders.
Notable figures associated with Eli Lilly include David A. Ricks, who serves as Chair, President, and CEO, and Anat Ashkenazi, the CFO. The company is publicly traded on the NYSE under the ticker LLY and is a component of both the S&P 100 and S&P 500 indices. With a revenue of $34.12 billion in 2023, Eli Lilly has made significant strides in the pharmaceutical industry, impacting millions of lives globally through its groundbreaking medical solutions.
Eli Lilly and Company - M & A Snapshot
Eli Lilly and Company - Quick Facts
Who are Eli Lilly and Company's competitors?
Companies similar to Eli Lilly and Company include Leal Therapeutics, Enveda Biosciences, Amylyx Pharmaceuticals and Triveni Bio.
When was Eli Lilly and Company founded?
Eli Lilly and Company was founded in 1876.
How many employees does Eli Lilly and Company have?
Eli Lilly and Company has 39,000 employees as of Feb 6, 2024.
